# Frequently Asked Questions
**What is KESIMPTA approved to treat?**
KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.
**How is KESIMPTA different from other B-cell treatments?**
KESIMPTA is the only B-cell treatment you can take once a month from the comfort of home using a prefilled auto-injector pen, unlike other B-cell therapies that require clinic visits for IV infusions.
**How often do I take KESIMPTA?**
KESIMPTA is taken once monthly after 3 weekly starter doses at weeks 0, 1, and 2, then monthly from week 4 onward.
**What results has KESIMPTA shown in clinical studies?**
KESIMPTA is proven to reduce relapses and disability progression in 2 studies versus teriflunomide, with a demonstrated safety profile.
**Can I administer KESIMPTA myself at home?**
Yes, KESIMPTA is self-administered at home using a prefilled auto-injector pen, eliminating the need for clinic infusion appointments.
**Who should not take KESIMPTA?**
Do not take KESIMPTA if you have an active hepatitis B virus (HBV) infection or have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.
**Is financial assistance available for KESIMPTA?**
Yes, 97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card, though limitations apply and the offer is not valid under Medicare, Medicaid, or other federal or state programs.
**What support is available to help me with KESIMPTA?**
The patient support program connects you with a dedicated Coordinator for one-on-one help throughout your treatment journey.
Leave a Reply